Piramal Pharma Limited announced levying the following penalties: INR 9,335,983 under the Cenvat Credit Rules, 2004 and Central Excise Act, 1944 by way of an order dated June 27, 2024 passed by the Joint Commissioner, C.G.S.T & Central Excise Headquarters, Ujjain, disallowing cenvat credit on certain category of services; and INR 58,661,571 under Central Goods and Services Tax, 2017 by way of an order dated May 31, 2024 passed by the Joint Commissioner, C.G.S.T & Central Excise, Commissionerate Indore, alleging mixed supply of goods and that this is subject to higher rate of GST; (collectively `Orders').
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
978.2 INR | +3.49% |
|
+6.02% | +5.02% |
06:13am | Jefferies Forecasts Strong Fiscal Q1 for Indian Pharmaceuticals | MT |
08/07 | Piramal Enterprises Limited Approves Final Dividend for the Financial Year Ended 31St March, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.02% | 255.03Cr | |
-3.67% | 5.22TCr | |
-4.52% | 3.06TCr | |
+52.56% | 2.7TCr | |
+39.42% | 2.66TCr | |
+32.81% | 2.04TCr | |
+11.91% | 1.42TCr | |
+24.27% | 882.09Cr | |
+166.22% | 804.3Cr | |
-26.33% | 774.94Cr |
- Stock Market
- Equities
- PEL Stock
- News Piramal Enterprises Limited
- Piramal Enterprises Limited Receives Levying Penalties